<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-30873" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Urosepsis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Porat</surname>
            <given-names>Avital</given-names>
          </name>
          <aff>University Of Connecticut</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bhutta</surname>
            <given-names>Beenish S.</given-names>
          </name>
          <aff>Sheikh Zayed Hospital, Lahore</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kesler</surname>
            <given-names>Stuart</given-names>
          </name>
          <aff>Hartford Hospital</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Avital Porat declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Beenish Bhutta declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Stuart Kesler declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>17</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-30873.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Sepsis is a systemic inflammatory response to infection that can lead to multi-organ dysfunction, failure, and even death. Urosepsis is sepsis caused by infections of the urinary tract, including cystitis, or lower urinary tract and bladder infections, and pyelonephritis, or upper urinary tract and kidney infections. Nearly 25 percent of sepsis cases originate from the urogenital tract. This activity reviews the etiology, pathophysiology, and presentation of urosepsis and highlights the role of the interprofessional team in the management of patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the pathophysiology of urosepsis.</p></list-item><list-item><p>Review the presentation of a patient with urosepsis.</p></list-item><list-item><p>Summarize the treatment and management options available for urosepsis.</p></list-item><list-item><p>Explain the importance of the interprofessional team in ensuring appropriate antibiotic administration in the management of patients with urosepsis.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30873&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30873">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-30873.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Sepsis is a clinical syndrome that is characterized by physiologic, biologic, and biochemical abnormalities caused by a dysregulated host response to infection. Sepsis and the associated inflammatory response can lead to multiple organ dysfunction syndrome and death. Urosepsis, as the name implies, is sepsis originating from the urogenital tract.<xref ref-type="bibr" rid="article-30873.r1">[1]</xref><xref ref-type="bibr" rid="article-30873.r2">[2]</xref></p>
      </sec>
      <sec id="article-30873.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The most common pathogen causing urinary tract infections (UTIs), and in turn&#x000a0;urosepsis, is&#x000a0;<italic toggle="yes">Escherichia coli</italic> (50%),&#x000a0;followed&#x000a0;by <italic toggle="yes">Proteus </italic>(15%), <italic toggle="yes">Enterobacter </italic>(15%), <italic toggle="yes">Klebsiella </italic>(15%), <italic toggle="yes">Pseudomonas aeruginosa</italic>&#x000a0;(5%), and gram-positive bacteria (15%).<xref ref-type="bibr" rid="article-30873.r3">[3]</xref><xref ref-type="bibr" rid="article-30873.r4">[4]</xref></p>
      </sec>
      <sec id="article-30873.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>In the United States, the number of sepsis cases appears to be increasing over the last 30 to 40 years, but the overall mortality of patients from sepsis has declined. It is estimated that the mortality rate from urosepsis is 30% to 40%. The severity of the disease also appears to be increasing and is typically associated with acute respiratory distress syndrome (ARDS), acute kidney injury, and disseminated intravascular coagulopathy (DIC).<xref ref-type="bibr" rid="article-30873.r5">[5]</xref><xref ref-type="bibr" rid="article-30873.r6">[6]</xref></p>
      </sec>
      <sec id="article-30873.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>A UTI begins with the colonization of the urethral meatus or vaginal introitus by either uropathogens or fecal flora that ascends via the urethra to the bladder. It may also ascend further up to the kidneys via the ureters and cause pyelonephritis. Pyelonephritis&#x000a0;also&#x000a0;can be caused by bacterial seeding of the kidneys via the lymphatics.<xref ref-type="bibr" rid="article-30873.r7">[7]</xref><xref ref-type="bibr" rid="article-30873.r8">[8]</xref></p>
        <p>While the bacterial pathogen causes the initiation of the disease process, the host response drives and defines sepsis and its severity. The immune response of the host is triggered when the proteins of the microbial pathogen interact with those of the host&#x02019;s cell membrane. The severe pro-inflammatory response can lead to cell necrosis, an increase in neutrophil production that produces bactericidal substances, and increased permeability of endothelial cells that lead to edema formation. After this initial phase, there is an anti-inflammatory response that leads to immunosuppression in the body where neutrophils become dysfunctional and cause further damage to nearby cells. Other systems in the body affected by this inflammatory response include&#x000a0;coagulation, autonomic, and endocrine systems.</p>
      </sec>
      <sec id="article-30873.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Urosepsis can present with a varying spectrum of signs and symptoms, as infection in different parts of the urogenital tract may present differently, as mentioned below:</p>
        <p>Cystitis presents with dysuria, urinary frequency and urgency, suprapubic pain, and hematuria. Patients may also have a fever or other systemic symptoms (including chills, rigors, or marked fatigue or malaise beyond baseline), which suggest that infection has extended beyond the bladder.<xref ref-type="bibr" rid="article-30873.r9">[9]</xref></p>
        <p>Pyelonephritis classically presents with fever, chills, flank pain, costovertebral angle tenderness, and nausea/vomiting. It may also be associated with symptoms of cystitis. Atypical symptoms include pain in the epigastrium or lower abdomen.<xref ref-type="bibr" rid="article-30873.r10">[10]</xref></p>
        <p>Acute bacterial prostatitis most commonly presents with&#x000a0;fevers, chills, dysuria, pelvic or perineal pain, and noticeably cloudy urine. Obstructive symptoms, such as dribbling of urine, can also occur. On examination, the prostate is often firm, edematous, and markedly tender.<xref ref-type="bibr" rid="article-30873.r11">[11]</xref></p>
        <p>Patients may also have recurrent UTIs, a history of renal stones, an immunocompromised state, or a chronic source of infection like an indwelling catheter.</p>
      </sec>
      <sec id="article-30873.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The diagnosis of urosepsis requires both suspicion of sepsis as well as evidence of a UTI. SIRS (systemic inflammatory response syndrome) signs and symptoms are indicators of sepsis but are no longer required for the formal diagnosis. This includes abnormalities in body temperature (warm skin), heart rate (bounding pulses, tachycardia), respiratory rate, and white blood cell count (elevation or depression). In more severe forms, sepsis is diagnosed when there is evidence of organ dysfunction, including but not limited to kidney dysfunction evidenced by decreased urine output, encephalopathy with an abrupt change in mental status, or a low platelet count. The diagnosis of a complicated UTI in the setting of SIRS includes signs and symptoms (dysuria, flank pain), physical exam findings (costovertebral angle tenderness, evidence of urinary retention), radiologic features, and laboratory results showing bacteriuria and leucocyturia.<xref ref-type="bibr" rid="article-30873.r12">[12]</xref><xref ref-type="bibr" rid="article-30873.r13">[13]</xref></p>
        <p>If urosepsis is suspected, the laboratory workup should include a urinalysis with a urine culture. Providers should also order a complete blood cell count, a comprehensive metabolic panel, blood cultures, and a lactate level to look for evidence of end-organ dysfunction. Post-renal obstruction is one of the most common causes of urosepsis. Ultrasound can identify 93% of common contributing causes of urosepsis, such as hydronephrosis or prostate abscess. However, the dependence on an experienced ultrasonographer and their availability often limit the utilization of ultrasound for such patients. Computed tomography (CT) imaging is rapidly available at all hours and is easily reproducible without a need for technologist expertise. This often makes CT scan the diagnostic modality of choice when urosepsis is suspected.&#x000a0;It can also identify subtle radiographic findings not easily visualized with ultrasound.<xref ref-type="bibr" rid="article-30873.r14">[14]</xref></p>
      </sec>
      <sec id="article-30873.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Over the last few decades, there has been an increase in multi-drug resistant organisms causing UTIs, making treatment more complicated. This is thought to stem from the overuse of antibiotics to treat suspected UTIs as confirmation is not available for 2 to 3 days until a urine culture with antimicrobial susceptibility has resulted.<xref ref-type="bibr" rid="article-30873.r15">[15]</xref><xref ref-type="bibr" rid="article-30873.r16">[16]</xref></p>
        <p>Research aimed at reducing mortality from sepsis via aggressive treatment modalities, including the original Rivers trial, has shown that early goal-directed therapy (EGDT) reduces&#x000a0;mortality from sepsis. While some of the original recommendations of EGDT have been challenged recently, these overall treatment guidelines remain: (1) Rapid initiation of empiric antibiotics that are chosen to eliminate the suspected source of infection, (2) Supportive care, including hemodynamic and pulmonary stabilization, and (3) Adjunctive therapies. When choosing antibiotics, the goal is to have these infused into the patient within one hour of a confirmed&#x000a0;diagnosis,&#x000a0;but they should be given only after urine and blood cultures have been collected. Each hour antibiotics are delayed after the initial six hours is associated with an 8% decrease in survival. Local susceptibility patterns guide antibiotic choice but often includes a third-generation cephalosporin, piperacillin in combination with a beta-lactamase inhibitor, or a fluoroquinolone. It is important to remember in dosing these antibiotics that many patients with severe sepsis have end-organ dysfunction, including renal and liver impairment, which might affect the clearance of antibiotics.<xref ref-type="bibr" rid="article-30873.r2">[2]</xref></p>
        <p>In addition to early antibiotics, there are other important parts of the management of sepsis. Initial fluid resuscitation with crystalloid is still recommended at a minimum of 30 mL/kg. Consider early administration of vasopressor support to maintain a mean arterial pressure greater than 65 mm Hg. The first choice for vasopressor support in sepsis is norepinephrine (with epinephrine and vasopressin 2 and 3). Tight glucose control is also recommended, with corticosteroids and blood products being more controversial in the literature.<xref ref-type="bibr" rid="article-30873.r17">[17]</xref></p>
        <p>If the patient has a complicating factor in the urinary tract that is identified and warrants treatment, it should be performed as soon as possible (e.g., Foley catheter placement to relieve urinary retention or stent placement to bypass an obstructing ureteral calculus causing urosepsis).</p>
      </sec>
      <sec id="article-30873.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Urosepsis, as mentioned above, includes a spectrum of urogenital tract infections, which may present differently, depending on the region and the extent of infection. It is important to probe the cause of infection, to treat them accordingly. Some of the causes are listed below:</p>
        <list list-type="bullet">
          <list-item>
            <p>Urinary tract infection</p>
          </list-item>
          <list-item>
            <p>Cystitis</p>
          </list-item>
          <list-item>
            <p>Pyelonephritis</p>
          </list-item>
          <list-item>
            <p>Acute bacterial prostatitis</p>
          </list-item>
          <list-item>
            <p>Prostatic abscess</p>
          </list-item>
          <list-item>
            <p>Renal abscess</p>
          </list-item>
          <list-item>
            <p>Urolithiasis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30873.s10" sec-type="Complications">
        <title>Complications</title>
        <p>Urosepsis is a treatable condition. However, delayed management can lead to severe consequences, including renal failure, septic shock, and death.<xref ref-type="bibr" rid="article-30873.r18">[18]</xref></p>
      </sec>
      <sec id="article-30873.s11" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients with risk factors for UTIs should be encouraged to seek care promptly if they develop symptoms of a UTI. Patients should also be made aware of the importance of adhering to their prescribed medication regimen.</p>
      </sec>
      <sec id="article-30873.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Urosepsis is best managed with an interprofessional team of health professionals that include a nephrologist, infectious disease expert, urologist, intensivist, a nurse, and a pharmacist. The key to preventing high morbidity is to prevent the condition that promotes infection. Any urological abnormality that is present needs to be corrected. The pharmacist should ensure that there is no delay in the administration of the antibiotics. The nurse should closely monitor the patient for signs of sepsis and communicate with the healthcare provider. Many of these patients require ICU care with close monitoring and frequent radiological studies. [Level 5]<xref ref-type="bibr" rid="article-30873.r19">[19]</xref><xref ref-type="bibr" rid="article-30873.r20">[20]</xref></p>
        <p>
<bold>Outcomes</bold>
</p>
        <p>The outcomes after urosepsis depend on the cause and severity of the infection. The prognosis also depends on the type of&#x000a0;bacteria, antimicrobial resistance, and patient comorbidity. This is where the input of a board-certified infectious disease pharmacist can be very beneficial, helping select appropriate antimicrobial coverage, check for drug interactions, and verify all dosing, and report any concerns to the clinical team. If left untreated, the condition has a very&#x000a0;high mortality. Even those who survive have a prolonged recovery period. Residual disturbance in renal function is not uncommon.<xref ref-type="bibr" rid="article-30873.r21">[21]</xref><xref ref-type="bibr" rid="article-30873.r22">[22]</xref> [Level 5]</p>
      </sec>
      <sec id="article-30873.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30873&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30873">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/kidney-health/urosepsis-urine-infection/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=30873">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/30873/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=30873">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-30873.s14">
        <title>References</title>
        <ref id="article-30873.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bj&#x000f6;rck</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>P&#x000e5;hlman</surname>
                <given-names>LI</given-names>
              </name>
              <name>
                <surname>Bodelsson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Petersson</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Kander</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Morbidity and mortality in critically ill patients with invasive group A streptococcus infection: an observational study.</article-title>
            <source>Crit Care</source>
            <year>2020</year>
            <month>Jun</month>
            <day>06</day>
            <volume>24</volume>
            <issue>1</issue>
            <fpage>302</fpage>
            <pub-id pub-id-type="pmid">32505194</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30873.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shimoni</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Salah</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kasem</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hermush</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Froom</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Bacterial Resistance to Cephalosporin Treatment in Elderly Stable Patients Hospitalized With a Urinary Tract Infection.</article-title>
            <source>Am J Med Sci</source>
            <year>2020</year>
            <month>Sep</month>
            <volume>360</volume>
            <issue>3</issue>
            <fpage>243</fpage>
            <page-range>243-247</page-range>
            <pub-id pub-id-type="pmid">32482350</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30873.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vikrant</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology and outcome of acute kidney injury from a tertiary care hospital in India.</article-title>
            <source>Saudi J Kidney Dis Transpl</source>
            <year>2018</year>
            <season>Jul-Aug</season>
            <volume>29</volume>
            <issue>4</issue>
            <fpage>956</fpage>
            <page-range>956-966</page-range>
            <pub-id pub-id-type="pmid">30152435</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30873.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scotland</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Lange</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Prevention and management of urosepsis triggered by ureteroscopy.</article-title>
            <source>Res Rep Urol</source>
            <year>2018</year>
            <volume>10</volume>
            <fpage>43</fpage>
            <page-range>43-49</page-range>
            <pub-id pub-id-type="pmid">30013956</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30873.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>YQ</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hao</surname>
                <given-names>YC</given-names>
              </name>
              <name>
                <surname>Xiao</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>LL</given-names>
              </name>
            </person-group>
            <article-title>[Predicting model based on risk factors for urosepsis after percutaneous nephrolithotomy].</article-title>
            <source>Beijing Da Xue Xue Bao Yi Xue Ban</source>
            <year>2018</year>
            <month>Jun</month>
            <day>18</day>
            <volume>50</volume>
            <issue>3</issue>
            <fpage>507</fpage>
            <page-range>507-513</page-range>
            <pub-id pub-id-type="pmid">29930421</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30873.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kozyrakis</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Perikleous</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chatzistamou</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Kateris</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Soukias</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Karatzas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dimitriadis</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Is There a Role for Double J Stent Culture in Contemporary Urology?</article-title>
            <source>Urol Int</source>
            <year>2018</year>
            <volume>100</volume>
            <issue>2</issue>
            <fpage>203</fpage>
            <page-range>203-208</page-range>
            <pub-id pub-id-type="pmid">29421810</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30873.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sarhan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>von M&#x000e4;ssenhausen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hugo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Oberbauer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Linkermann</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Immunological consequences of kidney cell death.</article-title>
            <source>Cell Death Dis</source>
            <year>2018</year>
            <month>Jan</month>
            <day>25</day>
            <volume>9</volume>
            <issue>2</issue>
            <fpage>114</fpage>
            <pub-id pub-id-type="pmid">29371597</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30873.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kodner</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Thomas Gupton</surname>
                <given-names>EK</given-names>
              </name>
            </person-group>
            <article-title>Recurrent urinary tract infections in women: diagnosis and management.</article-title>
            <source>Am Fam Physician</source>
            <year>2010</year>
            <month>Sep</month>
            <day>15</day>
            <volume>82</volume>
            <issue>6</issue>
            <fpage>638</fpage>
            <page-range>638-43</page-range>
            <pub-id pub-id-type="pmid">20842992</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30873.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saade</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Styczynski</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cesaro</surname>
                <given-names>S</given-names>
              </name>
              <collab>Infectious Disease Working party of EBMT</collab>
            </person-group>
            <article-title>BK virus infection in allogeneic hematopoietic cell transplantation: An update on pathogenesis, immune responses, diagnosis and treatments.</article-title>
            <source>J Infect</source>
            <year>2020</year>
            <month>Sep</month>
            <volume>81</volume>
            <issue>3</issue>
            <fpage>372</fpage>
            <page-range>372-382</page-range>
            <pub-id pub-id-type="pmid">32526327</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30873.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Parlak</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>A case of glomerulonephritis caused by brucellosis.</article-title>
            <source>Trop Doct</source>
            <year>2020</year>
            <month>Oct</month>
            <volume>50</volume>
            <issue>4</issue>
            <fpage>360</fpage>
            <page-range>360-361</page-range>
            <pub-id pub-id-type="pmid">32508259</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30873.r11">
          <label>11</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Reddivari</surname>
                <given-names>AKR</given-names>
              </name>
              <name>
                <surname>Mehta</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <chapter-title>Prostatic Abscess</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>5</month>
            <day>8</day>
            <pub-id pub-id-type="pmid">31869127</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30873.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vigil</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Hickling</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>Urinary tract infection in the neurogenic bladder.</article-title>
            <source>Transl Androl Urol</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>5</volume>
            <issue>1</issue>
            <fpage>72</fpage>
            <page-range>72-87</page-range>
            <pub-id pub-id-type="pmid">26904414</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30873.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dreger</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Degener</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ahmad-Nejad</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>W&#x000f6;bker</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Roth</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Urosepsis--Etiology, Diagnosis, and Treatment.</article-title>
            <source>Dtsch Arztebl Int</source>
            <year>2015</year>
            <month>Dec</month>
            <day>04</day>
            <volume>112</volume>
            <issue>49</issue>
            <fpage>837</fpage>
            <page-range>837-47; quiz 848</page-range>
            <pub-id pub-id-type="pmid">26754121</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30873.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bergevin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rivest</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Lapointe</surname>
                <given-names>SP</given-names>
              </name>
            </person-group>
            <article-title>Antibiotic prophylaxis for transrectal ultrasound-guided prostate needle biopsy: Compared efficacy of ciprofloxacin vs. the ciprofloxacin/fosfomycin tromethamine combination.</article-title>
            <source>Can Urol Assoc J</source>
            <year>2020</year>
            <month>Aug</month>
            <volume>14</volume>
            <issue>8</issue>
            <fpage>267</fpage>
            <page-range>267-272</page-range>
            <pub-id pub-id-type="pmid">32209218</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30873.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Caron</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Galperine</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Flateau</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Azria</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bonacorsi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bruy&#x000e8;re</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Cariou</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Clouqueur</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Doco-Lecompte</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Elefant</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Faure</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gauzit</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gavazzi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lemaitre</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Raymond</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Senneville</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sotto</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Subtil</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Trivalle</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Merens</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Etienne</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Practice guidelines for the management of adult community-acquired urinary tract infections.</article-title>
            <source>Med Mal Infect</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>48</volume>
            <issue>5</issue>
            <fpage>327</fpage>
            <page-range>327-358</page-range>
            <pub-id pub-id-type="pmid">29759852</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30873.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wagenlehner</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Tandogdu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Bjerklund Johansen</surname>
                <given-names>TE</given-names>
              </name>
            </person-group>
            <article-title>An update on classification and management of urosepsis.</article-title>
            <source>Curr Opin Urol</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>27</volume>
            <issue>2</issue>
            <fpage>133</fpage>
            <page-range>133-137</page-range>
            <pub-id pub-id-type="pmid">27846034</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30873.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reynolds</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Kroczak</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Pace</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>D'Arcy Honey</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Ordon</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JY</given-names>
              </name>
            </person-group>
            <article-title>Are Routine Laboratory Investigations Necessary Following Percutaneous Nephrolithotomy?</article-title>
            <source>Urology</source>
            <year>2020</year>
            <month>Sep</month>
            <volume>143</volume>
            <fpage>80</fpage>
            <page-range>80-84</page-range>
            <pub-id pub-id-type="pmid">32473206</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30873.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gr&#x000fc;ne</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Viehweger</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Waldbillig</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Nientiedt</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kriegmair</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Rassweiler-Seyfried</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Ritter</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Preoperative urine culture - Is it necessary to prevent infectious complications following ureterorenoscopy?</article-title>
            <source>J Microbiol Methods</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>173</volume>
            <fpage>105933</fpage>
            <pub-id pub-id-type="pmid">32325160</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30873.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heppner</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Yapan</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Wiedemann</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>[Urosepsis in Geriatric Patients].</article-title>
            <source>Aktuelle Urol</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>47</volume>
            <issue>1</issue>
            <fpage>54</fpage>
            <page-range>54-9</page-range>
            <pub-id pub-id-type="pmid">26916045</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30873.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goveas</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Urosepsis: A simple infection turns toxic.</article-title>
            <source>Nurse Pract</source>
            <year>2017</year>
            <month>Jul</month>
            <day>15</day>
            <volume>42</volume>
            <issue>7</issue>
            <fpage>53</fpage>
            <page-range>53-54</page-range>
            <pub-id pub-id-type="pmid">28622259</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30873.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pietropaolo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hendry</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kyriakides</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Geraghty</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Aboumarzouk</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Somani</surname>
                <given-names>BK</given-names>
              </name>
            </person-group>
            <article-title>Outcomes of Elective Ureteroscopy for Ureteric Stones in Patients with Prior Urosepsis and Emergency Drainage: Prospective Study over 5 yr from a Tertiary Endourology Centre.</article-title>
            <source>Eur Urol Focus</source>
            <year>2020</year>
            <month>Jan</month>
            <day>15</day>
            <volume>6</volume>
            <issue>1</issue>
            <fpage>151</fpage>
            <page-range>151-156</page-range>
            <pub-id pub-id-type="pmid">30219711</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30873.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Cui</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zeng</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Hequn</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Comparison of suctioning and traditional ureteral access sheath during flexible ureteroscopy in the treatment of renal stones.</article-title>
            <source>World J Urol</source>
            <year>2019</year>
            <month>May</month>
            <volume>37</volume>
            <issue>5</issue>
            <fpage>921</fpage>
            <page-range>921-929</page-range>
            <pub-id pub-id-type="pmid">30120500</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
